Repression of BDKRB2, but not B1 receptor, attenuated the bradykinin-mediated invasion and migration in colorectal cancer cells, and inhibited ERK1/2 activation and IL-6 production [31]. This evidence concerns the gene IL6 and colorectal cancer.